Related Experiment Video
Updated: Jan 10, 2026
A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
BST2 Drives Epithelial Ovarian Cancer Progression via Macrophage M2 Polarization, Neural Remodeling, and
Limin Zhang1,2,3, Xiaoli Huang2,3, Shaoyu Wang2,3
1College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China.
Background:
Epithelial ovarian cancer (EOC) ranks as the most lethal of gynecological cancers. Despite advances in therapeutic interventions that have marginally extended survival rates, the early detection and management of EOC pose significant hurdles. Consequently, identifying novel therapeutic targets is imperative for enhancing the survival outcomes of patients afflicted with this malignancy.
Purpose:
This research is aimed at exploring the functions of Bone Marrow Stromal Antigen 2 (BST2) in the pathogenesis of EOC and their influence on macrophage polarization, evaluating their viability as targets for immunotherapy.
Methods:
Gene expression profiles and clinical data of EOC patients were retrieved from the TCGA repository to develop prognostic models centered on BST2. The expression patterns of BST2 in HGSOC cell lines were quantified via RT-qPCR and Western blot analyses. The impact of BST2 on the proliferative, migratory, and invasive capacities of EOC cells was assessed through gene silencing and gene overexpression experiments.
Results:
Elevated levels of BST2 expression were observed in EOC tissues, correlating with adverse prognostic indicators. Enhanced BST2 expression facilitated EOC cell growth, motility, and invasiveness, whereas BST2 suppression mitigated these oncogenic attributes. In vivo assessments revealed that BST2 augmentation modified the macrophage phenotypes within grafted ovarian tumors, with BST2 diminution reversing these effects.
Conclusion:
The findings propose that BST2 acts as a pivotal facilitator in the progression of ovarian carcinoma. The expression metrics of BST2 may serve as prognostic markers for patient outcomes in EOC. These findings suggest that BST2 is a key promoter of ovarian cancer progression, and its expression may serve as a prognostic marker. The mechanisms uncovered, including the modulation of macrophage polarization and neural marker expression, indicate that targeting BST2 represents a potential future strategy for immunotherapy in EOC.
Insights
Bone Marrow Stromal Antigen 2 (BST2) promotes epithelial ovarian cancer (EOC) progression and influences macrophage polarization. BST2 expression levels may serve as prognostic markers for EOC patients, suggesting BST2 as a potential immunotherapy target.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Epithelial ovarian cancer (EOC) is a leading cause of gynecological cancer mortality.
- Current therapeutic interventions offer limited improvements in survival rates for EOC.
- Novel therapeutic targets are crucial for enhancing patient survival outcomes in EOC.
Purpose of the Study:
- To investigate the role of Bone Marrow Stromal Antigen 2 (BST2) in EOC pathogenesis.
- To explore BST2's influence on macrophage polarization in the context of EOC.
- To evaluate BST2 as a potential target for EOC immunotherapy.
Main Methods:
- Prognostic models for EOC were developed using TCGA gene expression and clinical data centered on BST2.
- BST2 expression was quantified in HGSOC cell lines using RT-qPCR and Western blot.
- Functional impacts of BST2 on EOC cell proliferation, migration, and invasion were assessed via gene silencing and overexpression.
Main Results:
- Elevated BST2 expression in EOC tissues correlated with poorer prognostic indicators.
- Increased BST2 expression enhanced EOC cell growth, motility, and invasiveness.
- BST2 modulation altered macrophage phenotypes in ovarian tumors, impacting tumor progression.
Conclusions:
- BST2 is identified as a key facilitator in ovarian carcinoma progression.
- BST2 expression levels show potential as prognostic markers for EOC patient outcomes.
- Targeting BST2, including its modulation of macrophage polarization, offers a promising avenue for EOC immunotherapy.
Related Concept Videos
02:17The Tumor Microenvironment
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...